title: Phase I/II study of monoclonal antibody against Lewis Y hapten in relapsed small-cell lung cancer.
authors.affiliation: Division of Oncology, University Hospital Zürich, Switzerland.
authors.forename: R A
authors.initials: RA
authors.lastname: Stahel
authors.forename: H
authors.initials: H
authors.lastname: Lacroix
authors.forename: J P
authors.initials: JP
authors.lastname: Sculier
authors.forename: R
authors.initials: R
authors.lastname: Morant
authors.forename: J
authors.initials: J
authors.lastname: Richner
authors.forename: E
authors.initials: E
authors.lastname: Janzek
authors.forename: H
authors.initials: H
authors.lastname: Loibner
authors.forename: H
authors.initials: H
authors.lastname: Blythman
mesh_terms: D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000276:immunology / Q000627:therapeutic use*; D018288:Carcinoma, Small Cell / Q000628:therapy*; D004341:Drug Evaluation; D006241:Haptens / Q000276:immunology*; D006801:Humans; D007983:Lewis Blood Group Antigens / Q000276:immunology*; D008175:Lung Neoplasms / Q000628:therapy*; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000628:therapy*
chemical_list: D000911:Antibodies, Monoclonal; D006241:Haptens; D007983:Lewis Blood Group Antigens